drugset
Drugs / Monovalent Oral Polio Vaccine Type 2 (mOPV2)
last change Mar 2018 re-read 2 minutes ago

Monovalent Oral Polio Vaccine Type 2 (mOPV2)

also known as monovalent oral type 2 polio vaccine · Monovalent Type 2 Oral Poliovirus Vaccine · mOPV2 · Polio Sabin Mono Two

Vaccine

Developed for
poliomyelitis
Investigated by
Bill and Melinda Gates Foundation · Fidec Corporation

Trials 1 · a red edge is where a trial was stopped

today NCT02582255 · Ph 4
20162017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02582255 Nov 2015 → Jul 2016 poliomyelitis Fidec Corporation Completed No outcome recorded
Also used as a comparator or background therapy in 2 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02643368 Comparator Dec 2015 → Feb 2016 poliomyelitis Centers for Disease Control and Prevention Completed No outcome recorded
Phase 4 NCT01831050 Background May 2013 → Apr 2014 poliomyelitis Fidec Corporation Completed No outcome recorded

Evidence & citations 7 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

FieldValueCited text
Known as Monovalent Oral Polio Vaccine Type 2 (mOPV2) ClinicalTrials.gov intervention name — accepted as the source's own label NCT01831050 ↗
Known as monovalent oral type 2 polio vaccine “Participants assigned to this intervention will receive a dose of monovalent oral type 2 polio vaccine (mOPV2) at 6 and 7 weeks of age” NCT02643368 ↗
Known as Monovalent Type 2 Oral Poliovirus Vaccine “Monovalent Type 2 Oral Poliovirus Vaccine (mOPV2) and inactivated poliovirus vaccine (IPV) are used to respond to type 2 poliovirus outbreaks.” PMID 29571817 ↗ Mar 2018
Known as mOPV2 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02643368 ↗
Known as Polio Sabin Mono Two “Polio Sabin™ Mono Two (oral) is a licensed, monovalent, live attenuated poliomyelitis virus vaccine of the Sabin strain Type 2 (P 712, Ch, 2ab), propagated in MRC5 human diploid cells.” NCT02582255 ↗
Modality Vaccine “monovalent, live attenuated poliomyelitis virus vaccine” NCT01831050 ↗
Route Oral “Polio Sabin Mono Two (oral)” NCT01831050 ↗